| Name | Title | Contact Details |
|---|
Rivian Automotive, Inc. is an American electric vehicle manufacturer founded in 2009 by Robert "RJ" Scaringe. Headquartered in Irvine, California, Rivian focuses on producing electric trucks and SUVs designed for sustainability. Its flagship models include the R1T, an all-electric pickup truck, and the R1S, an all-electric SUV, both known for their powerful electric motors and impressive performance capabilities. In addition to vehicle manufacturing, Rivian develops automotive technology, particularly in electric drivetrains and autonomous driving systems. The company is also exploring opportunities in ride-sharing and driverless car markets. Rivian has garnered significant investment from major corporations, including Amazon, which has placed large orders for electric delivery vans, and Ford Motor Company. With a strong focus on innovation and sustainability, Rivian aims to meet the growing demand for electric vehicles in both consumer and commercial markets.
Introducing QXO.
The Ken Ganley Automotive Group is the fastest growing dealership group in Northeast Ohio and beyond! We currently rank #1 in Ohio and #14 in the country. Our group is a collection of best-in-class dealerships that offer a wide array of quality new and used car models in convenient locations. At the Ken Ganley Auto Group, we believe that our people are our most important assets, along with our culture of leadership, integrity, customer focus and teamwork. Our people are the foundation of our brand, and our success is dependent on preserving our reputation of respect and quality. We are a company that believes in our core values and upholding them through great people, high standards and best practices. The core values of our organization are what shape every action we take and every decision that is made. We are defined by our integrity. We believe in doing what is right for our fellow team members, our customers and our corporate partners. We are responsive, professional, and handle every experience honestly and with class. Together, we have created an image that has resulted in a positive public perception. The image of a leader. Our customers are our #1 priority. We treat them like family, working hard to exceed their expectations. We are committed to continuing our tradition of success, performance and quality customer service. Our team members are entrusted to make sure each and every customer feels valued and listened to. When a customer enters our dealerships, they know they will have a dependable, quality experience every time. Thanks for visiting our page and well see you soon in the showrooms!
Tech Observer is a global Contract Research Organization (CRO) founded in 2005, with its headquarters in Paramus, New Jersey, and additional offices in New Delhi, Mumbai, and Singapore. The company specializes in clinical development support for the pharmaceutical, biotechnology, and medical device industries, extending its reach through local partners across the Asia-Pacific region. The company offers a comprehensive range of services that encompass the entire clinical research process. These include managing clinical trials, clinical data management, biostatistics and SAS programming, medical writing, post-marketing clinical studies, and staffing services. Tech Observer is ISO 9001:2008 and ISO 14155:2011 certified, demonstrating its commitment to quality and regulatory compliance. With a workforce of around 400 professionals, the company serves over 50 clients in more than 30 countries, focusing on various therapeutic areas such as oncology, cardiology, and infectious diseases. Tech Observer also emphasizes innovation with solutions like its AI-driven clinical trial risk tool, MyRBQM, and promotes diversity and professional growth within its team.
Synonym is accelerating the worlds biological future by developing, financing and building commercial-scale biomanufacturing facilities. We provide synthetic biology (synbio) producers – from startups to the Fortune 500 – with flexible production capacity while giving infrastructure investors access to a new, carbon-negative biomanufacturing asset class that we are calling "fermentation farms".